Search

Your search keyword '"Kaiser, Ulrich"' showing total 734 results

Search Constraints

Start Over You searched for: Author "Kaiser, Ulrich" Remove constraint Author: "Kaiser, Ulrich"
734 results on '"Kaiser, Ulrich"'

Search Results

51. Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial

52. Was bedeutet Open Science aus Sicht der Fachgesellschaften?

53. Competing for digital human capital: The retention effect of digital expertise in MNC subsidiaries

58. Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial

63. Tandem Duplications of the UBTF gene in Adult AML: A Rare but Recurrent Alteration Associated with Myelodysplasia and Poor Outcome

66. Identification of Disparities in Personalized Cancer Care—A Joint Approach of the German WERA Consortium

67. Maligne Lymphome

69. Mit Intelligenz von der Messung zur Information – VDI-Zukunftsforum in Ettlingen –.

72. Prognostic factors in non-small-cell lung cancer: insights from the German crisp registry

73. Mutated IKZF1is an independent marker of adverse risk in acute myeloid leukemia

74. Prognostic factors in nonsmall cell lung cancer: insights from the German CRISP registry

77. Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations

78. Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study

80. Intensified cytarabine dose during consolidation in AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry

82. Autorinnen und Autoren

83. SAPV-Patienten in der COVID-19-Krise

84. Additional file 1 of Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations

85. Wahnsinn!

88. Causes of mortality in elderly UICC stage III colon cancer (CC) patients––Tumor‐related death and competing risks from the German AIO colorectal study group Colopredict Plus (CPP) registry

92. Significant dose Escalation of Idarubicin in the treatment of aggressive Non- Hodgkin Lymphoma leads to increased hematotoxicity without improvement in efficacy in comparison to standard CHOEP-14: 9-year follow up results of the CIVEP trial of the DSHNHL

93. Wireless handheld focused ultrasound in student teaching during the COVID-19 pandemic: Initial results of a pilot study1.

94. Wireless handheld focused ultrasound in student teaching during the COVID-19 pandemic: Initial results of a pilot study1.

95. Mobile handheld ultrasound with VScan Air for the diagnosis of deep vein thrombosis.

99. Intensified Cytarabine Dose during Consolidation Therapy in AML Patients Under 65 Years Is Not Associated with Survival Benefit

100. Impact of Body Mass Index on Patient Outcome in Acute Myeloid Leukemia Patients Receiving Intensive Induction Therapy: A Real-World Registry Experience

Catalog

Books, media, physical & digital resources